Low concentration of lipopolysaccharide acts on MC3T3‐E1 osteoblasts and induces proliferation via the COX‐2‐independent NFκB pathway
Authors:
- 21 April 2009
- journal article
- research article
- Published by Wiley in Cell Biochemistry and Function
- Vol. 27 (4) , 238-242
Abstract
The translocations of lipopolysaccharide (LPS) from the gut and its effects on bone healing are usually of clinical interest during bone fracture. As already widely stuided, Cyclooxygenase‐2 (COX‐2) is a key enzyme for prostaglandin E2 (PGE2) production, which induces the nuclear factor kappa B (NFκB) activation and is beneficial to fracture healing. In order to know their roles in skeletal regeneration, mouse MC3T3‐E1 osteoblasts were treated with NFκB inhibitor BAY 11‐7082 and sc791 (a selective COX‐2 inhibitor), in the presence of LPS. Interestingly, LPS could induce osteoblasts proliferation through increasing NFκB activation and translocation. This induction was not related to COX‐2 expression, suggesting that LPS‐induced NFκB activiation is independent of COX‐2. It is possible that low concentration of LPS can act as a stimulating factor of the NFκB pathway in nonstimulated cells such as osteoblasts. COX‐2 is not necessary for the NFκB pathway during LPS‐induced proliferation of osteoblasts since sc791 had no effects on this induction. These studies provide insight into a potential mechanism by which LPS can affect bone tissue repair in the initial phase of inflammation. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 22 references indexed in Scilit:
- Sulforaphane suppresses lipopolysaccharide-induced cyclooxygenase-2 (COX-2) expression through the modulation of multiple targets in COX-2 gene promoterInternational Immunopharmacology, 2007
- Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblastsJournal of Periodontal Research, 2006
- Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-κB activationJournal of Ethnopharmacology, 2006
- Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblastsLife Sciences, 2006
- COX-2 is necessary for venous ligation-mediated bone adaptation in miceBone, 2006
- Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivityNature, 2001
- Lipopolysaccharide dependent cellular activationJournal of Periodontal Research, 1997
- Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.Journal of Clinical Investigation, 1996
- Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activityJournal of Cellular Biochemistry, 1994
- Regulation of Fracture Repair by Growth FactorsExperimental Biology and Medicine, 1992